L, K., S, N., S, L., A, S., S, C., S, B., . . . M, B. (2024). Adenosine Receptor 3 in Liver Cancer: Expression Variability, Epigenetic Modulation, and Enhanced Histone Deacetylase Inhibitor Effects. Gastro hep advances, 4(3), 100590. https://doi.org/10.1016/j.gastha.2024.11.006
Chicago Style (17th ed.) CitationL, Kaldjob-Heinrich, et al. "Adenosine Receptor 3 in Liver Cancer: Expression Variability, Epigenetic Modulation, and Enhanced Histone Deacetylase Inhibitor Effects." Gastro Hep Advances 4, no. 3 (2024): 100590. https://doi.org/10.1016/j.gastha.2024.11.006.
MLA (9th ed.) CitationL, Kaldjob-Heinrich, et al. "Adenosine Receptor 3 in Liver Cancer: Expression Variability, Epigenetic Modulation, and Enhanced Histone Deacetylase Inhibitor Effects." Gastro Hep Advances, vol. 4, no. 3, 2024, p. 100590, https://doi.org/10.1016/j.gastha.2024.11.006.